ReviewTherapeutic advances in drug safety2011

Metabolic activation of clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1.

Thomas M Polasek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.